{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:56:42Z","timestamp":1794711402950,"version":"4.9.1"},"reference-count":202,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T00:00:00Z","timestamp":1620345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000828","name":"Royal Society of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000828","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016045","name":"University of Central Punjab","doi-asserted-by":"publisher","award":["GP-25"],"award-info":[{"award-number":["GP-25"]}],"id":[{"id":"10.13039\/100016045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.biopha.2021.111708","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T07:36:44Z","timestamp":1620891404000},"page":"111708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":874,"special_numbering":"C","title":["Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management"],"prefix":"10.1016","volume":"139","author":[{"given":"Pushkar Singh","family":"Rawat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiswarya","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasvinder Singh","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umashanker","family":"Navik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.111708_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejphar.2017.10.043","article-title":"Molecular mechanism of doxorubicin-induced cardiomyopathy - an update","volume":"818","author":"Renu","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111708_bib2","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3389\/fphar.2018.01262","article-title":"Updates in anthracycline-mediated cardiotoxicity","volume":"9","author":"Nebigil","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111708_bib3","article-title":"Role of oxidation-dependent CaMKII activation in the genesis of abnormal action potentials in atrial cardiomyocytes: a simulation study","volume":"2020","author":"Zhao","year":"2020","journal-title":"BioMed Res. Int."},{"issue":"12","key":"10.1016\/j.biopha.2021.111708_bib4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/heartjnl-2017-312103","article-title":"Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention","volume":"104","author":"Henriksen","year":"2018","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.biopha.2021.111708_bib5","first-page":"135","article-title":"Chemotherapy-induced cardiotoxicity: pathophysiology and prevention","volume":"87","author":"Csapo","year":"2014","journal-title":"Clujul Med."},{"issue":"4","key":"10.1016\/j.biopha.2021.111708_bib6","first-page":"309","article-title":"Cardiotoxicity of anticancer treatments: epidemiology, detection, and management","volume":"66","author":"Curigliano","year":"2016","journal-title":"CA Cancer J. Clin."},{"issue":"22","key":"10.1016\/j.biopha.2021.111708_bib7","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1200\/JCO.2007.14.9401","article-title":"Anthracycline cardiotoxicity: from bench to bedside","volume":"26","author":"Gianni","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.biopha.2021.111708_bib8","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1200\/JCO.2007.14.9401","article-title":"Anthracycline cardiotoxicity: from bench to bedside","volume":"26","author":"Gianni","year":"2008","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111708_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/jpet.117.242388","article-title":"Modeling human myocardium exposure to doxorubicin defines the risk of heart failure from low-dose doxorubicin","volume":"362","author":"Salvatorelli","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2021.111708_bib10","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2174\/1568009618666171129222159","article-title":"Toxicology of trastuzumab: an insight into mechanisms of cardiotoxicity","volume":"19","author":"An","year":"2019","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.biopha.2021.111708_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cbi.2016.08.006","article-title":"Progress on the cardiotoxicity of sunitinib: prognostic significance, mechanism and protective therapies","volume":"257","author":"Yang","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.biopha.2021.111708_bib12","first-page":"13","article-title":"5-FU induced cardiotoxicity: case series and review of the literature","volume":"5","author":"Yuan","year":"2019","journal-title":"Cardiooncology"},{"key":"10.1016\/j.biopha.2021.111708_bib13","article-title":"Cardiotoxicity of imatinib is a\" surprise","volume":"24","author":"Chustecka","year":"2006","journal-title":"Nat. Med."},{"issue":"18","key":"10.1016\/j.biopha.2021.111708_bib14","doi-asserted-by":"crossref","first-page":"e560","DOI":"10.1200\/JCO.2011.35.5008","article-title":"Cardiotoxicity in patients treated with bevacizumab is potentially reversible","volume":"29","author":"Hawkes","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111708_bib15","article-title":"Report of cisplatin-induced cardiotoxicity: a side effect to monitor closely","volume":"3","author":"Mart\u00ednez-Mateo","year":"2017","journal-title":"J. Heart Health"},{"key":"10.1016\/j.biopha.2021.111708_bib16","series-title":"Drug Induced Cardiotoxicity: Mechanism, Prevention and Management","author":"Kelleni","year":"2018"},{"key":"10.1016\/j.biopha.2021.111708_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4965171","article-title":"The role of antioxidants in ameliorating cyclophosphamide-induced cardiotoxicity","volume":"2020","author":"Ayza","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.biopha.2021.111708_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.17294\/2330-0698.1025","article-title":"Diagnosis of chemotherapy-induced cardiotoxicity","volume":"1","author":"Pizzino","year":"2014","journal-title":"J. Patient Cent. Res. Rev."},{"issue":"10","key":"10.1016\/j.biopha.2021.111708_bib19","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1021\/bi00462a016","article-title":"Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin","volume":"29","author":"Frederick","year":"1990","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.biopha.2021.111708_bib20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/07388558509150782","article-title":"Anthracycline antibiotics","volume":"3","author":"Fujiwara","year":"1985","journal-title":"Crit. Rev. Biotechnol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111708_bib21","first-page":"670","article-title":"The anthracyclines: will we ever find a better doxorubicin?","volume":"19","author":"Weiss","year":"1992","journal-title":"Semin. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111708_bib22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0026-895X(25)10149-1","article-title":"Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells","volume":"45","author":"Fornari","year":"1994","journal-title":"Mol. Pharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2021.111708_bib23","first-page":"2891","article-title":"Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells","volume":"36","author":"Momparler","year":"1976","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.111708_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00003088-198815010-00002","article-title":"Clinical pharmacokinetics of doxorubicin","volume":"15","author":"Speth","year":"1988","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.biopha.2021.111708_bib25","unstructured":"M. Polovich, J. White, L. Kelleher, Chemotherapy and biotherapy guidelines and recommendations for practice Pittsburgh, PA: Oncology Nursing Society. 16 HOW SUPPLIED\/STORAGE AND HANDLING How Supplied VIDAZA (azacitidine for injection) is supplied as a lyophilized powder in 100 mg single-use vials packaged in cartons of 1 vial (NDC 59572\u2013102-01). Storage Store unreconstituted vials at 25C (77 F); excursions permitted to 15\u201330C (59\u201386 F)(See USP Controlled Room Temperature), Handling and Disposal Procedures for proper handling and disposal of anticancer drugs should be applied. Several guidelines on this subject have been published, (2005) 1\u20134."},{"issue":"1","key":"10.1016\/j.biopha.2021.111708_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/j.1552-4604.1996.tb04152.x","article-title":"Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi\u2019s sarcoma","volume":"36","author":"Northfelt","year":"1996","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111708_bib27","series-title":"American Society of Health System Pharmacists, Bethesda AHFS Drug Information","author":"McEvoy","year":"2008"},{"issue":"1","key":"10.1016\/j.biopha.2021.111708_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00003088-198815010-00002","article-title":"Clinical pharmacokinetics of doxorubicin","volume":"15","author":"Speth","year":"1988","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.biopha.2021.111708_bib29","article-title":"Pharmacokinetics of doxorubicin in normal weight and obese lymphoma patients","author":"Hoffmann","year":"2010","journal-title":"Am. Soc. Hematol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111708_bib30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0959-8049(97)00340-7","article-title":"Pharmacokinetics of anticancer agents in patients with impaired liver function","volume":"34","author":"Donelli","year":"1998","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2021.111708_bib31","series-title":"NIOSH Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings","first-page":"1","author":"Connor","year":"2004"},{"issue":"6","key":"10.1016\/j.biopha.2021.111708_bib32","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","article-title":"Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies","volume":"52","author":"Octavia","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.111708_bib33","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1006\/mgme.2000.3043","article-title":"Molecular basis of anthracycline-induced cardiotoxicity and its prevention","volume":"71","author":"Horenstein","year":"2000","journal-title":"Mol. Genet. Metab."},{"issue":"8","key":"10.1016\/j.biopha.2021.111708_bib34","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0024-3205(00)00990-5","article-title":"Effects by doxorubicin on the myocardium are mediated by oxygen free radicals","volume":"68","author":"Xu","year":"2001","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2021.111708_bib35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1734-1140(09)70018-0","article-title":"Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron","volume":"61","author":"Sim\u016fnek","year":"2009","journal-title":"Pharmacol. Rep."},{"issue":"38","key":"10.1016\/j.biopha.2021.111708_bib36","doi-asserted-by":"crossref","first-page":"11293","DOI":"10.1021\/bi971475e","article-title":"Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin","volume":"36","author":"V\u00e1squez-Vivar","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2021.111708_bib37","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1146\/annurev.ph.57.030195.003423","article-title":"Nitric oxide synthases: properties and catalytic mechanism","volume":"57","author":"Griffith","year":"1995","journal-title":"Annu. Rev. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111708_bib38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/01.RES.86.3.347","article-title":"Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide","volume":"86","author":"Drummond","year":"2000","journal-title":"Circ. Res."},{"issue":"50","key":"10.1016\/j.biopha.2021.111708_bib39","doi-asserted-by":"crossref","first-page":"47266","DOI":"10.1074\/jbc.M106829200","article-title":"Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase. Effect of antiapoptotic antioxidants and calcium","volume":"276","author":"Kalivendi","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2021.111708_bib40","doi-asserted-by":"crossref","first-page":"H1466","DOI":"10.1152\/ajpheart.00795.2008","article-title":"Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro","volume":"296","author":"Mukhopadhyay","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111708_bib41","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00356.2016","article-title":"Doxorubicin-induced nitrosative stress is mitigated by vitamin C via the modulation of nitric oxide synthases","volume":"312","author":"Akolkar","year":"2017","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111708_bib42","first-page":"759","article-title":"Nitric oxide synthase expressions in ADR-induced cardiomyopathy in rats","volume":"39","author":"Liu","year":"2006","journal-title":"J. Biochem Mol. Biol."},{"key":"10.1016\/j.biopha.2021.111708_bib43","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.yjmcc.2019.11.150","article-title":"Potential targets for intervention against doxorubicin-induced cardiotoxicity based on genetic studies: a systematic review of the literature","volume":"138","author":"Chen","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111708_bib44","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.abb.2004.04.030","article-title":"Human neuronal nitric oxide synthase can catalyze one-electron reduction of adriamycin: role of flavin domain","volume":"427","author":"Fu","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"issue":"7 Pt B","key":"10.1016\/j.biopha.2021.111708_bib45","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.bbamcr.2016.01.021","article-title":"New signal transduction paradigms in anthracycline-induced cardiotoxicity","volume":"1863","author":"Ghigo","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.biopha.2021.111708_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0005-2736(80)90145-5","article-title":"Evidence of a specific complex between adriamycin and negatively-charged phospholipids","volume":"597","author":"Goormaghtigh","year":"1980","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.biopha.2021.111708_bib47","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0163-7827(00)00005-9","article-title":"The biosynthesis and functional role of cardiolipin","volume":"39","author":"Schlame","year":"2000","journal-title":"Prog. Lipid Res."},{"issue":"7","key":"10.1016\/j.biopha.2021.111708_bib48","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/0006-2952(90)90438-Q","article-title":"Inhibition of mitochondrial carnitine palmitoyltransferases by adriamycin and adriamycin analogues","volume":"40","author":"Kashfi","year":"1990","journal-title":"Biochem. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.biopha.2021.111708_bib49","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tox.2010.01.019","article-title":"Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy","volume":"270","author":"Carvalho","year":"2010","journal-title":"Toxicology"},{"issue":"Pt 1","key":"10.1016\/j.biopha.2021.111708_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.2003.055095","article-title":"Energy metabolism in heart failure","volume":"555","author":"Ventura-Clapier","year":"2004","journal-title":"J. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111708_bib51","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11936-014-0315-4","article-title":"Anthracycline-induced cardiotoxicity: a review of pathophysiology, diagnosis, and treatment","volume":"16","author":"Raj","year":"2014","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"issue":"12","key":"10.1016\/j.biopha.2021.111708_bib52","first-page":"3730","article-title":"The CO\/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy","volume":"117","author":"Suliman","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2021.111708_bib53","first-page":"635","article-title":"In vivo studies on adriamycin-induced lipid peroxidation and effects of ferrous ions","volume":"8","author":"Kappus","year":"1980","journal-title":"Dev. Toxicol. Environ. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2021.111708_bib54","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/0006-2952(84)90340-X","article-title":"Lipid peroxidation and possible hydroxyl radical formation stimulated by the self-reduction of a doxorubicin-iron (III) complex","volume":"33","author":"Gutteridge","year":"1984","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111708_bib55","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol. Rev."},{"issue":"7","key":"10.1016\/j.biopha.2021.111708_bib56","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1096\/fasebj.12.7.541","article-title":"The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase\/iron regulatory protein-1 in cytosolic fractions from human myocardium","volume":"12","author":"Minotti","year":"1998","journal-title":"FASEB J."},{"issue":"23","key":"10.1016\/j.biopha.2021.111708_bib57","first-page":"8422","article-title":"Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy","volume":"61","author":"Minotti","year":"2001","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.biopha.2021.111708_bib58","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1182\/blood-2003-03-0869","article-title":"Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin","volume":"102","author":"Miranda","year":"2003","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.biopha.2021.111708_bib59","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.1093\/nar\/gkn774","article-title":"Interaction of anthracyclines with iron responsive element mRNAs","volume":"36","author":"Canzoneri","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.biopha.2021.111708_bib60","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0002-9629(15)40691-3","article-title":"Transfusion iron overload in adults with acute leukemia: manifestations and therapy","volume":"319","author":"Barton","year":"2000","journal-title":"Am. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2021.111708_bib61","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1172\/JCI72931","article-title":"Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation","volume":"124","author":"Ichikawa","year":"2014","journal-title":"J. Clin. Investig."},{"issue":"22","key":"10.1016\/j.biopha.2021.111708_bib62","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1158\/0008-5472.CAN-10-2664","article-title":"Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy","volume":"70","author":"Zhao","year":"2010","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.biopha.2021.111708_bib63","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/path.4255","article-title":"Emerging role of oxidative stress in metabolic syndrome and cardiovascular diseases: important role of Rac\/NADPH oxidase","volume":"231","author":"Elnakish","year":"2013","journal-title":"J. Pathol."},{"issue":"24","key":"10.1016\/j.biopha.2021.111708_bib64","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1161\/CIRCULATIONAHA.105.576850","article-title":"NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity","volume":"112","author":"Wojnowski","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.biopha.2021.111708_bib65","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.freeradbiomed.2006.11.013","article-title":"Gp91phox-containing NAD(P)H oxidase increases superoxide formation by doxorubicin and NADPH","volume":"42","author":"Deng","year":"2007","journal-title":"Free Radic. Biol. Med."},{"issue":"21","key":"10.1016\/j.biopha.2021.111708_bib66","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1111\/bph.13773","article-title":"Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2","volume":"174","author":"McLaughlin","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111708_bib67","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/cvr\/cvs309","article-title":"Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways","volume":"97","author":"Ma","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.biopha.2021.111708_bib68","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bbrc.2009.08.085","article-title":"NADPH oxidases participate to doxorubicin-induced cardiac myocyte apoptosis","volume":"388","author":"Gilleron","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Pt 2","key":"10.1016\/j.biopha.2021.111708_bib69","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1042\/BJ20050285","article-title":"Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium","volume":"389","author":"Kalivendi","year":"2005","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.biopha.2021.111708_bib70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0167-5273(90)90267-9","article-title":"A new insight into adriamycin-induced cardiotoxicity","volume":"29","author":"Fu","year":"1990","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2021.111708_bib71","series-title":"Doxorubicin-Induced Cardiotoxicity: From Mechanisms to Development of Efficient Therapy, Cardiotoxicity","author":"dos Santos","year":"2018"},{"issue":"6","key":"10.1016\/j.biopha.2021.111708_bib72","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1172\/JCI115241","article-title":"L-type cardiac calcium channels in doxorubicin cardiomyopathy in rats morphological, biochemical, and functional correlations","volume":"87","author":"Keung","year":"1991","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2021.111708_bib73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/128_2007_11","article-title":"Anthracycline cardiotoxicity","volume":"283","author":"Menna","year":"2008","journal-title":"Top. Curr. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2021.111708_bib74","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.febslet.2004.10.053","article-title":"Doxorubicin treatment in vivo activates caspase-12 mediated cardiac apoptosis in both male and female rats","volume":"577","author":"Jang","year":"2004","journal-title":"FEBS Lett."},{"issue":"9","key":"10.1016\/j.biopha.2021.111708_bib75","doi-asserted-by":"crossref","first-page":"8290","DOI":"10.1074\/jbc.M308033200","article-title":"Anthracyclines induce calpain-dependent titin proteolysis and necrosis in cardiomyocytes","volume":"279","author":"Lim","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2021.111708_bib76","first-page":"771","article-title":"Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin","volume":"61","author":"Zhou","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2021.111708_bib77","first-page":"17","article-title":"Doxorubicin induced heart failure: phenotype and molecular mechanisms","volume":"10","author":"Mitry","year":"2016","journal-title":"Int. J. Cardiol. Heart Vasc."},{"issue":"4","key":"10.1016\/j.biopha.2021.111708_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215992","article-title":"CaMKII activation participates in doxorubicin cardiotoxicity and is attenuated by moderate GRP78 overexpression","volume":"14","author":"Tscheschner","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2021.111708_bib79","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10557-020-06941-x","article-title":"The role of AMPK activation for cardioprotection in doxorubicin-induced cardiotoxicity","volume":"34","author":"Timm","year":"2020","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"7","key":"10.1016\/j.biopha.2021.111708_bib80","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/cdd.2015.95","article-title":"miR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activation","volume":"24","author":"Li","year":"2017","journal-title":"Cell Death Differ."},{"issue":"6","key":"10.1016\/j.biopha.2021.111708_bib81","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/jcmm.13053","article-title":"Autophagy: an adaptive physiological countermeasure to cellular senescence and ischaemia\/reperfusion-associated cardiac arrhythmias","volume":"21","author":"Lekli","year":"2017","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2021.111708_bib82","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1074\/jbc.M109.070037","article-title":"Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death","volume":"285","author":"Kobayashi","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2021.111708_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018005","article-title":"p53 Regulates oxidative stress-mediated retrograde signaling: a novel mechanism for chemotherapy-induced cardiac injury","volume":"6","author":"Velez","year":"2011","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.biopha.2021.111708_bib84","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1042\/BCJ20160385","article-title":"Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy","volume":"473","author":"Bartlett","year":"2016","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.biopha.2021.111708_bib85","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/CIRCULATIONAHA.108.799700","article-title":"Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway","volume":"119","author":"Zhu","year":"2009","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.biopha.2021.111708_bib86","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12013-011-9153-0","article-title":"Activation of AMP-activated protein kinase contributes to doxorubicin-induced cell death and apoptosis in cultured myocardial H9c2 cells","volume":"60","author":"Chen","year":"2011","journal-title":"Cell Biochem. Biophys."},{"issue":"28","key":"10.1016\/j.biopha.2021.111708_bib87","doi-asserted-by":"crossref","first-page":"46663","DOI":"10.18632\/oncotarget.16944","article-title":"Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity","volume":"8","author":"Koleini","year":"2017","journal-title":"Oncotarget"},{"issue":"09","key":"10.1016\/j.biopha.2021.111708_bib88","article-title":"Curcumin attenuates doxorubicin-induced cardiotoxicity by inducing autophagy via the regulation of JNK phosphorylation","volume":"5","author":"Katamura","year":"2014","journal-title":"J. Clin. Exp. Cardiol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111708_bib89","first-page":"762","article-title":"[Effect of curcumin on expression of survivin, Bcl-2 and Bax in human multiple myeloma cell line]","volume":"15","author":"Liu","year":"2007","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"6","key":"10.1016\/j.biopha.2021.111708_bib90","doi-asserted-by":"crossref","first-page":"H1832","DOI":"10.1152\/ajpheart.01047.2009","article-title":"Role of heat shock factor-1 activation in the doxorubicin-induced heart failure in mice","volume":"298","author":"Vedam","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111708_bib91","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.lfs.2006.09.019","article-title":"Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NF-kappaB activation","volume":"80","author":"Kim","year":"2007","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.biopha.2021.111708_bib92","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijcard.2006.01.010","article-title":"Protective effects of pyrrolidine dithiocarbamate on myocardium apoptosis induced by adriamycin in rats","volume":"114","author":"Li","year":"2007","journal-title":"Int. J. Cardiol."},{"issue":"Pt 3","key":"10.1016\/j.biopha.2021.111708_bib93","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1042\/bj20020752","article-title":"Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide","volume":"367","author":"Wang","year":"2002","journal-title":"Biochem. J."},{"issue":"20","key":"10.1016\/j.biopha.2021.111708_bib94","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012338","article-title":"Targeting extracellular heat shock protein 70 ameliorates doxorubicin-induced heart failure through resolution of toll-like receptor 2-mediated myocardial inflammation","volume":"8","author":"Liu","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"9","key":"10.1016\/j.biopha.2021.111708_bib95","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0022-2828(03)00229-3","article-title":"Hsp10 and Hsp60 modulate Bcl-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells","volume":"35","author":"Shan","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2021.111708_bib96","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fphar.2020.00257","article-title":"Heat shock protein 22 attenuates doxorubicin-induced cardiotoxicity via regulating inflammation and apoptosis","volume":"11","author":"Lan","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2021.111708_bib97","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/CIRCRESAHA.108.182832","article-title":"Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity","volume":"103","author":"Fan","year":"2008","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.biopha.2021.111708_bib98","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1254\/jphs.FP0050980","article-title":"Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo","volume":"101","author":"Ueno","year":"2006","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2021.111708_bib99","doi-asserted-by":"crossref","first-page":"44735","DOI":"10.1038\/srep44735","article-title":"Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.biopha.2021.111708_bib100","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1161\/CIRCRESAHA.109.209643","article-title":"Extracellular heat shock protein 60, cardiac myocytes, and apoptosis","volume":"105","author":"Kim","year":"2009","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.biopha.2021.111708_bib101","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/CIRCRESAHA.108.172155","article-title":"Extracellular release of the atheroprotective heat shock protein 27 is mediated by estrogen and competitively inhibits acLDL binding to scavenger receptor-A","volume":"103","author":"Rayner","year":"2008","journal-title":"Circ. Res."},{"issue":"13","key":"10.1016\/j.biopha.2021.111708_bib102","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1093\/emboj\/19.13.3325","article-title":"The apoptotic signaling pathway activated by Toll-like receptor-2","volume":"19","author":"Aliprantis","year":"2000","journal-title":"EMBO J."},{"issue":"21","key":"10.1016\/j.biopha.2021.111708_bib103","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1158\/0008-5472.CAN-07-1344","article-title":"The endothelin receptor blocker bosentan inhibits doxorubicin-induced cardiomyopathy","volume":"67","author":"Bien","year":"2007","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2021.111708_bib104","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/01.CIR.0000105701.98663.D4","article-title":"Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice","volume":"109","author":"Yang","year":"2004","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.biopha.2021.111708_bib105","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.healun.2009.06.025","article-title":"Alteration of matrix metalloproteinases in selective left ventricular adriamycin-induced cardiomyopathy in the pig","volume":"28","author":"Goetzenich","year":"2009","journal-title":"J. Heart Lung Transpl."},{"issue":"3","key":"10.1016\/j.biopha.2021.111708_bib106","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.cardiores.2005.08.009","article-title":"Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase","volume":"69","author":"Spallarossa","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2021.111708_bib107","doi-asserted-by":"crossref","unstructured":"C. Dupont, D.R. Armant, C.A. Brenner, Epigenetics: definition, mechanisms and clinical perspective, Seminars in reproductive medicine, \u00a9 Thieme Medical Publishers, (2009), pp. 351\u2013357.","DOI":"10.1055\/s-0029-1237423"},{"issue":"6","key":"10.1016\/j.biopha.2021.111708_bib108","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrg2341","article-title":"DNA methylation landscapes: provocative insights from epigenomics","volume":"9","author":"Suzuki","year":"2008","journal-title":"Nat. Rev. Genet."},{"issue":"3","key":"10.1016\/j.biopha.2021.111708_bib109","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.fertnstert.2013.01.117","article-title":"Basic concepts of epigenetics","volume":"99","author":"Inbar-Feigenberg","year":"2013","journal-title":"Fertil. Steril."},{"issue":"7336","key":"10.1016\/j.biopha.2021.111708_bib110","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature09798","article-title":"Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells","volume":"471","author":"Lister","year":"2011","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.111708_bib111","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-1119(01)00721-1","article-title":"Epigenetics: interaction of DNA methylation and chromatin","volume":"278","author":"Nakao","year":"2001","journal-title":"Gene"},{"key":"10.1016\/j.biopha.2021.111708_bib112","article-title":"Collins dictionary of human biology","author":"Youngson","year":"2006","journal-title":"Collins"},{"key":"10.1016\/j.biopha.2021.111708_bib113","series-title":"Research Methodologies and Practical Applications of Chemistry","author":"Pogliani","year":"2019"},{"issue":"5696","key":"10.1016\/j.biopha.2021.111708_bib114","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.1105136","article-title":"The ENCODE (ENCyclopedia of DNA elements) project","volume":"306","author":"Consortium","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.biopha.2021.111708_bib115","unstructured":"I. Dunham, E. Birney, B.R. Lajoie, A. Sanyal, X. Dong, M. Greven, X. Lin, J. Wang, T.W. Whitfield, J. Zhuang, An integrated encyclopedia of DNA elements in the human genome, (2012)."},{"key":"10.1016\/j.biopha.2021.111708_bib116","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-animal-020518-115206","article-title":"One-carbon metabolism: linking nutritional biochemistry to epigenetic programming of long-term development","volume":"7","author":"Clare","year":"2019","journal-title":"Annu. Rev. Anim. Biosci."},{"key":"10.1016\/j.biopha.2021.111708_bib117","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.tox.2017.08.011","article-title":"Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity","volume":"390","author":"Ferreira","year":"2017","journal-title":"Toxicology"},{"issue":"9","key":"10.1016\/j.biopha.2021.111708_bib118","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1073\/pnas.1012311108","article-title":"DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria","volume":"108","author":"Shock","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2021.111708_bib119","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fcvm.2020.00056","article-title":"Review on the role of epigenetic modifications in doxorubicin-induced cardiotoxicity","volume":"7","author":"Kumari","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2021.111708_bib120","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.yjmcc.2018.10.007","article-title":"HDAC6 inhibition protects cardiomyocytes against doxorubicin-induced acute damage by improving \u03b1-tubulin acetylation","volume":"124","author":"Song","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2021.111708_bib121","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/ncomms2921","article-title":"Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin","volume":"4","author":"Pang","year":"2013","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2021.111708_bib122","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/cvr\/cvr097","article-title":"Non-coding RNAs as regulators of gene expression and epigenetics","volume":"90","author":"Kaikkonen","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.111708_bib123","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10741-017-9653-0","article-title":"Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients","volume":"23","author":"Ruggeri","year":"2018","journal-title":"Heart Fail. Rev."},{"issue":"7","key":"10.1016\/j.biopha.2021.111708_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040395","article-title":"Perturbation of microRNAs in rat heart during chronic doxorubicin treatment","volume":"7","author":"Vacchi-Suzzi","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.biopha.2021.111708_bib125","doi-asserted-by":"crossref","first-page":"14511","DOI":"10.3390\/ijms160714511","article-title":"MiR-21 protected cardiomyocytes against doxorubicin-induced apoptosis by targeting BTG2","volume":"16","author":"Tong","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.111708_bib126","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/597032","article-title":"MicroRNA-208a silencing attenuates doxorubicin induced myocyte apoptosis and cardiac dysfunction","volume":"2015","author":"Tony","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.biopha.2021.111708_bib127","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/cvr\/cvq148","article-title":"Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway","volume":"87","author":"Horie","year":"2010","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.biopha.2021.111708_bib128","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.89","article-title":"Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in \u03b2-adrenergic signaling and enhances apoptosis","volume":"6","author":"Roca-Alonso","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2021.111708_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2019.110628","article-title":"Metformin alleviates oxidative stress and enhances autophagy in diabetic kidney disease via AMPK\/SIRT1-FoxO1 pathway","volume":"500","author":"Ren","year":"2020","journal-title":"Mol. Cell. Endocrinol."},{"issue":"8","key":"10.1016\/j.biopha.2021.111708_bib130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104888","article-title":"Metformin protects cardiomyocyte from doxorubicin induced cytotoxicity through an AMP-activated protein kinase dependent signaling pathway: an in vitro study","volume":"9","author":"Kobashigawa","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.biopha.2021.111708_bib131","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/jama.2019.0015","article-title":"Management of blood cholesterol","volume":"321","author":"Alenghat","year":"2019","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.biopha.2021.111708_bib132","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1161\/CIRCULATIONAHA.106.630194","article-title":"Statins activate AMP-activated protein kinase in vitro and in vivo","volume":"114","author":"Sun","year":"2006","journal-title":"Circulation"},{"issue":"29","key":"10.1016\/j.biopha.2021.111708_bib133","doi-asserted-by":"crossref","first-page":"20186","DOI":"10.1074\/jbc.M803020200","article-title":"Reactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivo","volume":"283","author":"Choi","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"22","key":"10.1016\/j.biopha.2021.111708_bib134","doi-asserted-by":"crossref","first-page":"14734","DOI":"10.1074\/jbc.M808664200","article-title":"Regulation of Rac1 by simvastatin in endothelial cells: differential roles of AMP-activated protein kinase and calmodulin-dependent kinase kinase-beta","volume":"284","author":"Kou","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2021.111708_bib135","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/CRD.0000000000000252","article-title":"The preventive role of angiotensin converting enzyme inhibitors\/angiotensin-II receptor blockers and \u03b2-adrenergic blockers in anthracycline- and trastuzumab-induced cardiotoxicity","volume":"27","author":"Blanter","year":"2019","journal-title":"Cardiol. Rev."},{"issue":"11","key":"10.1016\/j.biopha.2021.111708_bib136","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.jacc.2006.07.052","article-title":"Protective effects of carvedilol against anthracycline-induced cardiomyopathy","volume":"48","author":"Kalay","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"13","key":"10.1016\/j.biopha.2021.111708_bib137","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1161\/01.CIR.0000160359.49478.C2","article-title":"Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity","volume":"111","author":"Fisher","year":"2005","journal-title":"Circulation"},{"issue":"42","key":"10.1016\/j.biopha.2021.111708_bib138","doi-asserted-by":"crossref","first-page":"18202","DOI":"10.1073\/pnas.1006965107","article-title":"Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction","volume":"107","author":"Das","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"18","key":"10.1016\/j.biopha.2021.111708_bib139","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1073\/pnas.0401833101","article-title":"Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity","volume":"101","author":"Aries","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2021.111708_bib140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jacbts.2016.10.006","article-title":"An oral selective alpha-1A adrenergic receptor agonist prevents doxorubicin cardiotoxicity","volume":"2","author":"Beak","year":"2017","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.biopha.2021.111708_bib141","series-title":"xPharm: The Comprehensive Pharmacology Reference","first-page":"1","author":"Mack","year":"2007"},{"issue":"9","key":"10.1016\/j.biopha.2021.111708_bib142","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1124\/dmd.105.005546","article-title":"Metabolism of the one-ring open metabolites of the cardioprotective drug dexrazoxane to its active metal-chelating form in the rat","volume":"33","author":"Schroeder","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.biopha.2021.111708_bib143","first-page":"144","article-title":"Resveratrol in prostate diseases - a short review","volume":"66","author":"Jasi\u0144ski","year":"2013","journal-title":"Cent. Eur. J. Urol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111708_bib144","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/10715760802673008","article-title":"Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage","volume":"43","author":"Tatlidede","year":"2009","journal-title":"Free Radic. Res."},{"issue":"22","key":"10.1016\/j.biopha.2021.111708_bib145","doi-asserted-by":"crossref","first-page":"10061","DOI":"10.18632\/aging.102418","article-title":"PGC1\u03b1 activation by pterostilbene ameliorates acute doxorubicin cardiotoxicity by reducing oxidative stress via enhancing AMPK and SIRT1 cascades","volume":"11","author":"Liu","year":"2019","journal-title":"Aging"},{"key":"10.1016\/j.biopha.2021.111708_bib146","series-title":"Present Knowledge in Nutrition: Basic Nutrition and Metabolism","author":"Marriott","year":"2020"},{"issue":"8","key":"10.1016\/j.biopha.2021.111708_bib147","doi-asserted-by":"crossref","DOI":"10.3390\/nu9080849","article-title":"Impact of frequency of multi-vitamin\/multi-mineral supplement intake on nutritional adequacy and nutrient deficiencies in U.S. adults","volume":"9","author":"Blumberg","year":"2017","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.biopha.2021.111708_bib148","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00280-003-0676-y","article-title":"New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicity","volume":"52","author":"El-Demerdash","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111708_bib149","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/01.CIR.91.1.10","article-title":"Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect","volume":"91","author":"Siveski-Iliskovic","year":"1995","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.biopha.2021.111708_bib150","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1161\/01.CIR.89.6.2829","article-title":"Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats","volume":"89","author":"Siveski-Iliskovic","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2021.111708_bib151","series-title":"Selected Phyto and Marine Bioactive Compounds: Alternatives for the Treatment of Type 2 Diabetes, Studies in Natural Products Chemistry","first-page":"111","author":"Reyes","year":"2018"},{"issue":"4","key":"10.1016\/j.biopha.2021.111708_bib152","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00280-017-3413-7","article-title":"Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis","volume":"80","author":"Abdel-Daim","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2021.111708_bib153","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/CIRCRESAHA.113.300218","article-title":"Emerging paradigms in cardiomyopathies associated with cancer therapies","volume":"113","author":"Ky","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2021.111708_bib154","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/ijpvm.IJPVM_193_20","article-title":"Adiponectin: role in physiology and pathophysiology","volume":"11","author":"Nguyen","year":"2020","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.biopha.2021.111708_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2020.09.035","article-title":"Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress","author":"Zhao","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2021.111708_bib156","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fphys.2015.00167","article-title":"Renal erythropoietin-producing cells in health and disease","volume":"6","author":"Souma","year":"2015","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111708_bib157","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3181\/0706-RM-152","article-title":"Erythropoietin pretreatment protects against acute chemotherapy toxicity in isolated rat hearts","volume":"233","author":"Ramond","year":"2008","journal-title":"Exp. Biol. Med."},{"issue":"13","key":"10.1016\/j.biopha.2021.111708_bib158","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1200\/JCO.2009.25.1835","article-title":"Epoetin alfa in patients with advanced-stage Hodgkin\u2019s lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial","volume":"28","author":"Engert","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111708_bib159","doi-asserted-by":"crossref","first-page":"849","DOI":"10.21037\/cdt-20-490","article-title":"MiR-181c protects cardiomyocyte injury by preventing cell apoptosis through PI3K\/Akt signaling pathway","volume":"10","author":"Li","year":"2020","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"10.1016\/j.biopha.2021.111708_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112627","article-title":"Anticancer property of ginsenoside Rh2 from ginseng","volume":"203","author":"Li","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"2\u20133","key":"10.1016\/j.biopha.2021.111708_bib161","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.tox.2006.11.053","article-title":"Preventive effect of naringin on cardiac markers, electrocardiographic patterns and lysosomal hydrolases in normal and isoproterenol-induced myocardial infarction in Wistar rats","volume":"230","author":"Rajadurai","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.biopha.2021.111708_bib162","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/506214","article-title":"Cardioprotective effects of 20(S)-Ginsenoside Rh2 against doxorubicin-induced cardiotoxicity in vitro and in vivo","volume":"2012","author":"Wang","year":"2012","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2021.111708_bib163","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/B978-0-12-802215-3.00008-2","article-title":"Curcumin: a potent modulator of multiple enzymes in multiple cancers","volume":"36","author":"Shehzad","year":"2014","journal-title":"Enzymes"},{"key":"10.1016\/j.biopha.2021.111708_bib164","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-12-800173-8.00003-9","article-title":"Curcumin","volume":"39","author":"Lestari","year":"2014","journal-title":"Profiles Drug Subst. Excip. Relat. Methodol."},{"issue":"2","key":"10.1016\/j.biopha.2021.111708_bib165","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00056.2019","article-title":"Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis","volume":"317","author":"Tavakoli Dargani","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2021.111708_bib166","doi-asserted-by":"crossref","first-page":"45126","DOI":"10.1038\/srep45126","article-title":"Differential roles of caspase-1 and caspase-11 in infection and inflammation","volume":"7","author":"Man","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2021.111708_bib167","doi-asserted-by":"crossref","first-page":"752","DOI":"10.21037\/cdt-19-707","article-title":"Curcumin suppresses doxorubicin-induced cardiomyocyte pyroptosis via a PI3K\/Akt\/mTOR-dependent manner","volume":"10","author":"Yu","year":"2020","journal-title":"Cardiovasc. Diagn. Ther."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.111708_bib168","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejps.2011.10.023","article-title":"Nonlinear pharmacokinetics of visnagin in rats after intravenous bolus administration","volume":"45","author":"Haug","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"issue":"266","key":"10.1016\/j.biopha.2021.111708_bib169","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010189","article-title":"Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase","volume":"6","author":"Liu","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.biopha.2021.111708_bib170","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0167-4838(92)90476-T","article-title":"Malate dehydrogenase isoenzymes: cellular locations and role in the flow of metabolites between the cytoplasm and cell organelles","volume":"1100","author":"Gietl","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.biopha.2021.111708_bib171","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/cvr\/cvr051","article-title":"Metabolic fingerprint of ischaemic cardioprotection: importance of the malate-aspartate shuttle","volume":"91","author":"Nielsen","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2021.111708_bib172","series-title":"Natural Products and Drug Discovery","first-page":"73","article-title":"Development of Chinese herbal health products for the prevention of aging-associated diseases","author":"Leong","year":"2018"},{"issue":"8","key":"10.1016\/j.biopha.2021.111708_bib173","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/01616412.2020.1782079","article-title":"Schisandrin B improves cerebral ischemia and reduces reperfusion injury in rats through TLR4\/NF-\u03baB signaling pathway inhibition","volume":"42","author":"Fan","year":"2020","journal-title":"Neurol. Res."},{"issue":"22 Pt 1","key":"10.1016\/j.biopha.2021.111708_bib174","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1158\/1078-0432.CCR-07-1579","article-title":"Schisandrin B prevents doxorubicin-induced cardiotoxicity via enhancing glutathione redox cycling","volume":"13","author":"Li","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.111708_bib175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/CIRCULATIONAHA.108.799700","article-title":"Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mTOR pathway","volume":"119","author":"Zhu","year":"2009","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.biopha.2021.111708_bib176","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028335","article-title":"Schisandrin B prevents doxorubicin-induced chronic cardiotoxicity and enhances its anticancer activity in vivo","volume":"6","author":"Xu","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biopha.2021.111708_bib177","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077713","article-title":"Attenuation of doxorubicin-induced cardiotoxicity by mdivi-1: a mitochondrial division\/mitophagy inhibitor","volume":"8","author":"Gharanei","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.111708_bib178","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yjmcc.2017.06.003","article-title":"LCZ696 improves cardiac function via alleviating Drp1-mediated mitochondrial dysfunction in mice with doxorubicin-induced dilated cardiomyopathy","volume":"108","author":"Xia","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2021.111708_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104846","article-title":"Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission","volume":"157","author":"Liang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2021.111708_bib180","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fphys.2020.00113","article-title":"Luteolin attenuates doxorubicin-induced cardiotoxicity through promoting mitochondrial autophagy","volume":"11","author":"Xu","year":"2020","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111708_bib181","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/jpi.12176","article-title":"Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin","volume":"57","author":"Govender","year":"2014","journal-title":"J. Pineal Res."},{"issue":"12","key":"10.1016\/j.biopha.2021.111708_bib182","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1038\/s12276-020-00541-3","article-title":"Melatonin prevents doxorubicin-induced cardiotoxicity through suppression of AMPK\u03b12-dependent mitochondrial damage","volume":"52","author":"Yang","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2021.111708_bib183","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.apsb.2018.10.008","article-title":"Chrysophanol protects against doxorubicin-induced cardiotoxicity by suppressing cellular PARylation","volume":"9","author":"Lu","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"issue":"5","key":"10.1016\/j.biopha.2021.111708_bib184","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.3390\/md12052922","article-title":"Echinochrome A protects mitochondrial function in cardiomyocytes against cardiotoxic drugs","volume":"12","author":"Jeong","year":"2014","journal-title":"Mar. Drugs"},{"issue":"2\u20133","key":"10.1016\/j.biopha.2021.111708_bib185","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tox.2008.02.018","article-title":"Ghrelin prevents doxorubicin-induced cardiotoxicity through TNF-alpha\/NF-kappaB pathways and mitochondrial protective mechanisms","volume":"247","author":"Xu","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.biopha.2021.111708_bib186","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.mito.2017.02.005","article-title":"Intravenous administration of mitochondria for treating experimental Parkinson\u2019s disease","volume":"34","author":"Shi","year":"2017","journal-title":"Mitochondrion"},{"issue":"4","key":"10.1016\/j.biopha.2021.111708_bib187","doi-asserted-by":"crossref","first-page":"22716","DOI":"10.1002\/jbt.22716","article-title":"Proanthocyanidin alleviates doxorubicin-induced cardiac injury by inhibiting NF-kB pathway and modulating oxidative stress, cell cycle, and fibrogenesis","volume":"35","author":"Sadek","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111708_bib188","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.11938","article-title":"Hydrogen sulfide ameliorates doxorubicin\u2011induced myocardial fibrosis in rats via the PI3K\/AKT\/mTOR pathway","volume":"23","author":"Nie","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2021.111708_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118984","article-title":"Tranilast prevents doxorubicin-induced myocardial hypertrophy and angiotensin II synthesis in rats","volume":"267","author":"Zhan","year":"2021","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.biopha.2021.111708_bib190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22063269","article-title":"Cardiac protective effect of kirenol against doxorubicin-induced cardiac hypertrophy in H9c2 cells through Nrf2 signaling via PI3K\/AKT pathways","volume":"22","author":"Alzahrani","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2021.111708_bib191","first-page":"1","article-title":"Cardioprotective effect of Malva verticillata against doxorubicin-induced toxicity in rats","volume":"7","author":"Almutawakel","year":"2021","journal-title":"Clin. Phytosci."},{"issue":"7","key":"10.1016\/j.biopha.2021.111708_bib192","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.3390\/molecules26071946","article-title":"Protective effect of two alkaloids from hippophae rhamnoides linn. against doxorubicin-induced toxicity in H9c2 cardiomyoblasts","volume":"26","author":"Zhou","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2021.111708_bib193","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6694340","article-title":"Methyl gallate attenuates doxorubicin-induced cardiotoxicity in rats by suppressing oxidative stress","volume":"2021","author":"Ahmed","year":"2021","journal-title":"Scientifica"},{"key":"10.1016\/j.biopha.2021.111708_bib194","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5896931","article-title":"Xinmailong attenuates doxorubicin-induced lysosomal dysfunction and oxidative stress in H9c2 cells via HO-1","volume":"2021","author":"Jiang","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.biopha.2021.111708_bib195","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3892\/ijmm.2021.4896","article-title":"Peptide Szeto\u2011Schiller 31 ameliorates doxorubicin\u2011induced cardiotoxicity by inhibiting the activation of the p38 MAPK signaling pathway","volume":"47","author":"Zhang","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2021.111708_bib196","first-page":"1","article-title":"Chia seed oil ameliorates doxorubicin-induced cardiotoxicity in female wistar rats: an electrocardiographic, biochemical and histopathological approach","author":"Ahmed","year":"2021","journal-title":"Cardiovasc. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2021.111708_bib197","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4103\/mmj.mmj_5_20","article-title":"Possible protective effects of quercetin on doxorubicin-induced cardiotoxicity in rats","volume":"34","author":"Hashish","year":"2021","journal-title":"Menoufia Med. J."},{"key":"10.1016\/j.biopha.2021.111708_bib198","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.freeradbiomed.2020.10.303","article-title":"Xanthine oxidase inhibition attenuates doxorubicin-induced cardiotoxicity in mice","volume":"162","author":"Tanaka","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2021.111708_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2021.103142","article-title":"Calycosin-triblock copolymer nanomicelles attenuate doxorubicin-induced cardiotoxicity through upregulation of ERp57","volume":"14","author":"Wang","year":"2021","journal-title":"Arab. J. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2021.111708_bib200","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ymthe.2020.12.035","article-title":"Telomerase therapy attenuates cardiotoxic effects of doxorubicin","volume":"29","author":"Chatterjee","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2021.111708_bib201","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111531","article-title":"Compound Danshen Dripping Pill inhibits doxorubicin or isoproterenol-induced cardiotoxicity","volume":"138","author":"Feng","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2021.111708_bib202","doi-asserted-by":"crossref","first-page":"22618","DOI":"10.1002\/jbt.22618","article-title":"Thymoquinone attenuates doxorubicin-cardiotoxicity in rats","volume":"35","author":"Karabulut","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222100490X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222100490X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:44:32Z","timestamp":1760100272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222100490X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":202,"alternative-id":["S075333222100490X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111708","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111708","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111708"}}